New BIO Survey on Effective FDA – Sponsor Communication During Drug Development
BIO is surveying members on their interactions with the FDA during the various stages of drug development prior to submitting an NDA/BLA. The survey can be accessed here. In an increasingly competitive...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?
Is 2014 a good time to invest in biotech? How many biotech IPOs will there be? Which sectors will perform the best? To find out what investors think about these questions and more, BIO is conducting...
View Article
More Pages to Explore .....
